| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/22/1998 | US5811082 Wax particles containing dispersed metal oxide particles |
| 09/22/1998 | US5811005 Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix |
| 09/22/1998 | CA2135603C Solid dispersion compositions of tebufelone |
| 09/22/1998 | CA2128244C Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
| 09/22/1998 | CA2128242C Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets |
| 09/22/1998 | CA2117584C Gels for encapsulation of biological materials |
| 09/22/1998 | CA2115279C Pharmaceutical products with a content of dexpanthenol for topical applications |
| 09/22/1998 | CA2050679C Preparation of liposome and lipid complex compositions |
| 09/17/1998 | WO1998040502A1 Peptide-enhanced transfections |
| 09/17/1998 | WO1998040498A2 Immunoadhesins and methods of production and use thereof |
| 09/17/1998 | WO1998040409A1 Site protected protein modification |
| 09/17/1998 | WO1998040406A1 Calcium phosphopeptide complexes |
| 09/17/1998 | WO1998040401A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | WO1998040350A1 Salicylic acid-sphingoid base derivatives and uses thereof |
| 09/17/1998 | WO1998040104A2 Covalent conjugates of topoisomerase i and topoisomerase ii inhibitors |
| 09/17/1998 | WO1998040100A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| 09/17/1998 | WO1998040094A1 Hydrophilic binary systems for the administration of cyclosporine |
| 09/17/1998 | WO1998040069A2 Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 09/17/1998 | WO1998040060A1 Solid, non-deliquescent formulations of sodium valproate |
| 09/17/1998 | WO1998040052A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/17/1998 | WO1998040051A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
| 09/17/1998 | WO1998032467A3 Method and conjugate for treating h. pylori infection |
| 09/17/1998 | WO1998031394A3 Tissue factor methods and compositions for coagulation and tumor treatment |
| 09/17/1998 | WO1998031343A3 Aqueous suspension for nasal administration of loteprednol |
| 09/17/1998 | WO1998019710A3 Delivery of nucleic acid material to target cells in biological systems |
| 09/17/1998 | DE19706490C1 Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen Process for the preparation of acid amides and the metalation of compounds and use of the compounds prepared by the processes |
| 09/17/1998 | CA2727634A1 Calcium fluoride phosphate complexes |
| 09/17/1998 | CA2283780A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 09/17/1998 | CA2283557A1 Use of nucleic acids containing unmethylated cpg dinucleotide as an adjuvant |
| 09/17/1998 | CA2283228A1 Device for controlled anaesthesia, analgesia and/or sedation |
| 09/17/1998 | CA2283227A1 Medicinal preparation containing a lipophilic inert gas |
| 09/17/1998 | CA2282807A1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 09/17/1998 | CA2254078A1 Solid, non-deliquescent formulations of sodium valproate |
| 09/16/1998 | EP0864646A2 Process for the inactivation of enveloped viruses |
| 09/16/1998 | EP0864324A1 Method to produce solid combined pharmaceutical forms |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0864319A1 Topical composition containing a sulfonated polyester hydrophilic gelling agent |
| 09/16/1998 | EP0863946A1 Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide) |
| 09/16/1998 | EP0863933A1 Novel hydrogels containing triblock copolymers, and preparation and use thereof |
| 09/16/1998 | EP0863917A1 Targeted cytotoxic anthracycline analogs |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863769A1 Glycoconjugates as virus cell adhesion inhibitors |
| 09/16/1998 | EP0863768A2 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 09/16/1998 | EP0863767A2 Powdery iodine complexes |
| 09/16/1998 | EP0863765A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 09/16/1998 | EP0863762A1 Methods of production and use of liquid formulations of plasma proteins |
| 09/16/1998 | EP0863749A2 Complex cationic lipids |
| 09/16/1998 | EP0863747A1 Stimulation of hair follicles |
| 09/16/1998 | EP0863745A1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 09/16/1998 | EP0863743A1 Skin care preparation and method |
| 09/16/1998 | EP0863729A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 09/16/1998 | EP0863704A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 09/16/1998 | EP0810854A4 Aerosols containing beclomethazone nanoparticle dispersions |
| 09/16/1998 | EP0763063A4 Lysozyme-degradable biomaterials |
| 09/16/1998 | EP0662841B1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 09/16/1998 | EP0598719B1 Receptor conjugates for targeting drugs and other agents |
| 09/16/1998 | EP0577602B1 Transdermal contraceptive formulations, methods and devices |
| 09/16/1998 | EP0554356B1 A monoclonal antibody |
| 09/16/1998 | EP0541556B1 Stabilization of biological macromolecular substances and other organic compounds |
| 09/16/1998 | CN1193279A Hyperbranched polymers |
| 09/16/1998 | CN1193278A Chemical compounds |
| 09/16/1998 | CN1193275A Percutaneous tap preparation containing fentanyl |
| 09/16/1998 | CN1192929A Oral medicinal preparation |
| 09/15/1998 | US5808137 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumors |
| 09/15/1998 | US5808096 Process for preparing active carbonates of polyalkylene oxides for modification of polypeptides |
| 09/15/1998 | US5808059 Matrix-supported sapphyrins |
| 09/15/1998 | US5808027 N-2 substituted purines in oligonucleotides |
| 09/15/1998 | US5808023 Modified oligonucleotides |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808003 Polyaminocarboxylate chelators |
| 09/15/1998 | US5807971 Core with polyoxaalkylene branches |
| 09/15/1998 | US5807957 Cationic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
| 09/15/1998 | US5807881 Method for selectively reducing activated leukocyte cell population |
| 09/15/1998 | US5807879 Biotinidase-resistant biotinylated compound and methods of use thereof |
| 09/15/1998 | US5807844 Therapy for septic shock, infections, toxicity |
| 09/15/1998 | US5807833 Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device |
| 09/15/1998 | US5807832 Oral delivery of biologically active substances bound to vitamin B12 |
| 09/15/1998 | US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/15/1998 | US5807830 Method for treatment of purulent inflammatory diseases |
| 09/15/1998 | US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 09/15/1998 | US5807820 Cyclosporin compositions for topical application |
| 09/15/1998 | US5807757 Controlling particle size distribution |
| 09/15/1998 | US5807746 Administering signal peptide complex; antisense therapy, gene transfer |
| 09/15/1998 | US5807734 Polypeptide |
| 09/15/1998 | US5807581 Collagen-based injectable drug delivery system and its use |
| 09/15/1998 | US5807574 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
| 09/15/1998 | US5807573 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
| 09/15/1998 | US5807568 Enhanced delivery of topical compositions containing flurbiprofen |
| 09/15/1998 | US5807567 Calcium sulfate controlled release matrix |
| 09/15/1998 | US5807553 Immonogenic oligosaccharide compositions |
| 09/15/1998 | US5807534 In vivo binding pair pretargeting |
| 09/14/1998 | CA2231977A1 Aqueous suspension of loteprednol etabonate |
| 09/11/1998 | WO1998039467A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 09/11/1998 | WO1998039466A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 09/11/1998 | WO1998039465A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 09/11/1998 | WO1998039464A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 09/11/1998 | WO1998039363A2 Immunotoxins and methods of inducing immune tolerance |
| 09/11/1998 | WO1998039037A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 09/11/1998 | WO1998039023A1 Treatment of cardiomyopathy |